Toward high-throughput, low-latency structural biology using light, Part I: Protein-ligand pose determination

We demonstrate for the first time that an optical spectroscopy - electron-vibration-vibration two-dimensional infrared spectroscopy (EVV 2DIR) - has sufficient structural competence to enable the reconstruction of the three-dimensional geometries of drug-protein binding at the level needed for practical drug discovery applications. Klug et al. previously demonstrated experimental detection of drug binding to a kinase using EVV 2DIR. Here we use a quantum mechanical approach to calculate and assign elements of EVV 2DIR spectra for the spectral region 1200-1800 cm$^{-1}$ / 1100-1800 cm$^{-1}$ of 92 protein-ligand complexes. This dataset includes ligand-target poses drawn from existing crystal structures and ligand-target poses created by docking and cofolding models. We find that binding-dependent spectral features are robust, interpretable, and consistent across poses in a given binding mode, and distinct for each unique hydrogen bonding geometry. We construct a spectral distance metric to distinguish poses that conform to the ligand-target hydrogen-bonding pattern of the crystal structure from those that do not. These results show that, given a set of predicted ligand-target poses containing the correct geometry, the hydrogen-bonding pattern of the valid pose may be rapidly identified by comparing simulated and experimental EVV 2DIR spectra. Finally, we discuss the practical implications for a new, high throughput structural biology for drug discovery that will be the subject of forthcoming manuscripts, noting that the base technologies to perform EVV 2DIR quickly and efficiently already exist and will enable a novel structure to be determined in only minutes for each sample. Moreover, this can be achieved without the need for crystallization, isotopic labeling, or low temperatures, non-destructively using picogram quantities of material.

Authors

Publication Details

Journal
arXiv (Cornell University)
Published
2026-11-18
DOI
https://doi.org/10.48550/arxiv.2611.24901
Primary Topic
Spectroscopy Techniques in Biomedical and Chemical Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Toward high-throughput, low-latency structural biology using light, Part I: Protein-ligand pose determination

David R. Klug, Brian K. Petkov
arXiv (Cornell University)
Spectroscopy Techniques in Biomedical and Chemical Research
preprint

Toward high-throughput, low-latency structural biology using light, Part I: Protein-ligand pose determination

David R. Klug, Brian K. Petkov
preprint en

Abstract

We demonstrate for the first time that an optical spectroscopy - electron-vibration-vibration two-dimensional infrared spectroscopy (EVV 2DIR) - has sufficient structural competence to enable the reconstruction of the three-dimensional geometries of drug-protein binding at the level needed for practical drug discovery applications. Klug et al. previously demonstrated experimental detection of drug binding to a kinase using EVV 2DIR. Here we use a quantum mechanical approach to calculate and assign elements of EVV 2DIR spectra for the spectral region 1200-1800 cm$^{-1}$ / 1100-1800 cm$^{-1}$ of 92 protein-ligand complexes. This dataset includes ligand-target poses drawn from existing crystal structures and ligand-target poses created by docking and cofolding models. We find that binding-dependent spectral features are robust, interpretable, and consistent across poses in a given binding mode, and distinct for each unique hydrogen bonding geometry. We construct a spectral distance metric to distinguish poses that conform to the ligand-target hydrogen-bonding pattern of the crystal structure from those that do not. These results show that, given a set of predicted ligand-target poses containing the correct geometry, the hydrogen-bonding pattern of the valid pose may be rapidly identified by comparing simulated and experimental EVV 2DIR spectra. Finally, we discuss the practical implications for a new, high throughput structural biology for drug discovery that will be the subject of forthcoming manuscripts, noting that the base technologies to perform EVV 2DIR quickly and efficiently already exist and will enable a novel structure to be determined in only minutes for each sample. Moreover, this can be achieved without the need for crystallization, isotopic labeling, or low temperatures, non-destructively using picogram quantities of material.

arXiv (Cornell University)
Spectroscopy Techniques in Biomedical and Chemical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon